Liver autophagy-induced valine and leucine in plasma reflect the metabolic effect of sodium glucose co-transporter 2 inhibitor dapagliflozin-Reference-Cited by-同舟云学术

Liver autophagy-induced valine and leucine in plasma reflect the metabolic effect of sodium glucose co-transporter 2 inhibitor dapagliflozin

Published:2022-12 Issue: Volume:86 Page:104342
ISSN:2352-3964
Container-title:eBioMedicine
language:en
Short-container-title:eBioMedicine

Author:

Furuya Futoshi,Fujita Yoshihito,Matsuo Naomi,Minamino Hiroto^ORCID,Oguri Yasuo,Isomura Nozomi,Ikeda Kaori,Takesue Kohei,Li Ying^ORCID,Kondo Aki,Mano Fumika,Inagaki Nobuya

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference51 articles.

1. Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American diabetes association (ADA) and the European association for the study of diabetes (EASD);Davies;Diabetes Care,2018

2. Type 2 diabetes - an autoinflammatory disease driven by metabolic stress;Gonzalez;Biochim Biophys Acta, Mol Basis Dis,2018

3. Obesity and nonalcoholic fatty liver disease: current perspectives;Sarwar;Diabetes Metab Syndrome Obes Targets Ther,2018

4. Obesity and cardiovascular disease: revisiting an old relationship;Koliaki;Metabol Clin Exp,2019

5. The renal effects of SGLT2 inhibitors and a mini-review of the literature;Andrianesis;Therapeut Adv Endocrinol Metabol,2016

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autophagy alterations in obesity, type 2 diabetes, and metabolic dysfunction-associated steatotic liver disease: the evidence from human studies;Internal and Emergency Medicine;2024-07-06

2. SGLT1 and SGLT2 inhibition, circulating metabolites, and cerebral small vessel disease: a mediation Mendelian Randomization study;Cardiovascular Diabetology;2024-05-07

3. Biomarkers for Assessing Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus on Sodium–Glucose Cotransporter 2 Inhibitor Therapy;Journal of Clinical Medicine;2023-10-16

4. SGLT2 inhibitors and autophagy in diabetes;Cell Biochemistry and Function;2023-04-10